Pimecrolimus [137071-32-0]
P3348
Estimated Purity≥99%
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NamePimecrolimus [137071-32-0]
- Delivery Days Customer7
- CertificationResearch Use Only
- Estimated Purity≥99%
- FormatSoluble in DMSO (25 mg/mL). Soluble in ethanol (25 mg/mL). Soluble in chloroform, methanol.
- Scientific DescriptionCalcineurin inhibitor, potential TRPV1 agonist.; 33-epi-chloro-33-desoxyascomycin; Elidel; SDZ-ASM 981; SDZ ASM 981; SDZ-ASM-981; Picrolimus; ASM981; ASM-981; ASM 981
- Storage InstructionAmbient
- UNSPSC12352200
References
- Xie ZQ, Lan YZ. Effectiveness of pimecrolimus cream for women patients with sensitive skin and its underlying mechanism. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2012 Aug;34(4):375-8. PMID: 22954121. Lampropoulos CE, D'Cruz DP. Topical calcineurin inhibitors in systemic lupus erythematosus. Ther Clin Risk Manag. 2010 Apr 15;6:95-101. PMID: 20421909. Hultsch T, Kapp A, Spergel J. Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology. 2005;211(2):174-87. Review. Erratum in: Dermatology. 2005;211(3):292. PMID: 16088174. Lipozencić J. Pimecrolimus--a safe and effective local immunomodulator in the treatment of inflammatory skin diseases. Acta Dermatovenerol Croat. 2005;13(1):63-9. PMID: 15788149. Gupta AK, Chow M. Pimecrolimus: a review. J Eur Acad Dermatol Venereol. 2003 Sep;17(5):493-503. PMID: 12941081.